ASP-liposomes that contained encapsulated asparaginase did not inhibit the growth of the studied tumor cells (inhibition < 1%), possibly due to a slow liposome degradation that prevents asparaginase release or to an instability of the released enzyme, with a subsequent loss of catalytic activity. This evidence concerns the gene ASPG and neoplasm.